Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Pain Relief in Nasal Septum Resection
NCT02294162Withdrawn
- Sponsor
- Galilee Medical Center
- Start
- Apr 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative pain comparing Ketamine with Placebo (2 arms). Primary endpoints: Reduction in pain severity based on VAS score and Consumption of postoperative pain medication. Planned start Apr 2015; status: withdrawn.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02294162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294162.